Alerts will be sent to your verified email
Verify Email
BALPHARMA
Insufficient data
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Bal Pharma Limited is a leading Indian pharmaceutical company with over 25 years of experience. They specialize in prescription drugs, generics, intravenous infusions, and have state-of-the-art manufacturing facilities across India.
Bal Pharma major competitors are Tyche Inds, Smruthi Organics, Mangalam Drugs&Org., Lasa Supergenerics, Nectar Lifesciences, Haleos Labs, Everest Organics.
Market Cap of Bal Pharma is ₹141 Crs.
While the median market cap of its peers are ₹138 Crs.
Bal Pharma seems to be less financially stable compared to its competitors.
Altman Z score of Bal Pharma is 1.96 and is ranked 6 out of its 8 competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | Mar Jun Sep Dec | Mar Jun Sep Dec | ||||||||||||||||
| Investor Presentation | Jun Sep Dec | |||||||||||||||||
| Conference Call | ||||||||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
